LATIN AMERICA AND THE CARIBBEAN - Number of new cases 1 581 498, deaths 759 717, prevalent cases (5-year) 4 004 249 (Statistics at a glance, 2024)

Oct 22, 2026

Uploaded by Patrick

Statistics at a glance, 2024, summarize cancer incidence, mortality, and 5-year prevalence for Latin America and the Caribbean. The document reports 1,581,498 new cases and 759,717 cancer deaths, with 4,004,249 prevalent cases (5-year). It provides age-standardized incidence and mortality rates for males, females, and both sexes, plus cumulative risks before age 75. It also highlights leading cancer types by cases and deaths and presents incidence, death counts, and 5-year prevalence by cancer site.

LanguageEnglish

CategoryResearch & Report

FormatPDF

Pages2

Reading Time5 min

AccessFree to download

Statistics at a glance, 2024

Incidence (new cancer cases)

Mortality (cancer deaths)

Prevalence (5-year prevalent cases)

Population and included regions

Top frequent cancers

Incidence, Mortality and Prevalence by cancer site

Data source and methods

G LO BO CA N 2 02 4 LATIN AMERICA AND THE CARIBBEAN Number of new cases 1 581 498 Number of deaths 759 717 Number of prevalent cases (5-year) 4 004 249 Statistics at a glance, 2024 | | Males | Females | Both sexes | | --- | --- | --- | --- | | Population | 326 522 506 | 336 943 576 | 663 466 077 | | Incidence* | | | | | Number of new cancer cases | 764 314 | 817 184 | 1 581 498 | | Age-standardized incidence rate | 192.6 | 180.4 | 184.0 | | Risk of developing cancer before the age of 75 years (cum. risk %) | 18.9 | 17.3 | 18.0 | | Top 3 leading cancers (ranked by cases)** | Prostate | Breast | Breast | | | Colorectum | Colorectum | Prostate | | | Lung | Cervix uteri | Colorectum | | Mortality* | | | | | Number of cancer deaths | 388 466 | 371 251 | 759 717 | | Age-standardized mortality rate | 96.0 | 77.3 | 85.0 | | Risk of dying from cancer before the age of 75 years (cum. risk %) | 9.5 | 7.9 | 8.6 | | Top 3 leading cancers (ranked by deaths)** | Prostate | Breast | Lung | | | Lung | Colorectum | Colorectum | | | Colorectum | Lung | Prostate | | Prevalence* | | | | | 5-year prevalent cases | 1 787 367 | 2 216 882 | 4 004 249 | | | | | | Population( s) included: South America, Caribbean, Central America Kilometers 0 0.05 0.1 0.2 Top 5 most frequent cancers** Males Others Liver Prostate Colorectum Lung Stomach Total: 764 314 Rank Cancer site Number of cases Percent Females Others Lung Breast Colorectum Cervix uteri Thyroid Total: 817 184 Rank Cancer site Number of cases Percent Both sexes Total: 1 581 498 Rank Cancer site Number of cases Percent | 1st |
Prostate |
215 448 |
28.2% |
1st | Breast |
218 121 |
26.7% | 1st |
Breast |
218 121 |
13.8% | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | 2nd Colorectum 77 206 10. 1% 2nd Colorectum 76 247 9.3% 2nd Prostate 215 448 13.6% 3rd Cervix uteri 66 200 8. 1% 3rd Colorectum 153 453 9.7% Stomach 47 212 6.2% 4th Thyroid 47 208 5.8% 4th Lung 103 726 6.6% 5th Lung 43 152 5.3% 5th Stomach 79 706 5.0% The Global Cancer Observatory | All rights reserved | GLOBOCAN 2024-September, 2026 Page 1 | Incidence, Mortality and Prevalence by cancer site | | | | | --- | --- | --- | --- | | | New cases | Deaths |
5-year prevalence
Number Prop. (per 100 000) | |
Cancer | Number Rank (%) Cum.risk | Number Rank (%) Cum.risk | | | Breast | 218 121 1 13.8 5.3 | 61 565 4 8.1 1.4 | 670 478 199.0 | |
Prostate | 215 448 2 13.6 5.8 | 63 058 3 8.3 1.1 | 518 681 158.9 | | Colorectum | 153 453 3 9.7 2.0 | 76 117 2 10.0 0.87 | 414 926 62.5 | |
Lung | 103 726 4 6.6 1.4 | 89 548 1 11.8 1.2 | 141 589 21.3 | | Stomach | 79 706 5 5.0 0.99 | 58 181 5 7.7 0.69 | 118 150 17.8 | |
Cervix uteri | 66 200 6 4.2 1.6 | 33 068 8 4.4 0.78 | 215 942 64.1 | | Thyroid | 57 837 7 3.7 0.72 | 4 817 23 0.63 0.06 | 193 285 29.1 | |
Liver | 44 006 8 2.8 0.55 | 40 818 6 5.4 0.51 | 56 980 8.6 | | Leukaemia | 42 782 9 2.7 0.49 | 27 797 9 3.7 0.31 | 128 222 19.3 | |
NHL | 42 721 10 2.7 0.55 | 18 495 12 2.4 0.23 | 125 551 18.9 | | Pancreas | 41 490 11 2.6 0.50 | 39 090 7 5.1 0.48 | 40 596 6.1 | |
Corpus uteri | 38 342 12 2.4 1.0 | 9 252 18 1.2 0.23 | 122 531 36.4 | | Kidney | 38 309 13 2.4 0.52 | 15 636 14 2.1 0.20 | 113 655 17.1 | |
Bladder | 32 347 14 2.0 0.37 | 13 725 15 1.8 0.13 | 92 988 14.0 | | Brain CNS | 27 774 15 1.8 0.35 | 23 229 10 3.1 0.30 | 98 201 14.8 | |
Ovary | 26 914 16 1.7 0.66 | 15 684 13 2.1 0.39 | 72 800 21.6 | | Oesophagus | 21 578 17 1.4 0.29 | 19 439 11 2.6 0.25 | 29 786 4.5 | |
Lip, oral cavity | 20 187 18 1.3 0.26 | 8 718 19 1.1 0.11 | 54 701 8.2 | | Melanoma | 20 179 19 1.3 0.23 | 5 770 21 0.76 0.06 | 67 724 10.2 | |
Larynx | 18 005 20 1.1 0.26 | 10 639 17 1.4 0.15 | 51 003 7.7 | | Multiple myeloma | 16 799 21 1.1 0.23 | 11 132 16 1.5 0.15 | 44 380 6.7 | |
Testis | 11 822 22 0.75

FAQs

What are the headline cancer figures for Latin America and the Caribbean in 2024?

The report lists 1,581,498 new cancer cases, 759,717 cancer deaths, and 4,004,249 five-year prevalent cases.

How does the document compare males, females, and both sexes?

It provides incidence, mortality, age-standardized rates, and cumulative risks before age 75 separately for males, females, and both sexes, alongside totals.

Which cancers are identified as leading by new cases and by deaths?

Top leading cancers by cases and by deaths are ranked and shown separately, including major sites such as prostate, breast, colorectal, lung, and cervix uteri.

Oct 22, 2026

Uploaded by Patrick